Azacytidine and Venetoclax in Relapsed and Refractory Patients With Angioimmunoblastic T-cell Lymphoma

Kamel Laribi, Alix Baugier de Materre, Yamina Touileb, Charles Boursot, Jeremy Sandrini, Doriane Cavalieri, Cédric Pastoret, Laurence de Leval, Olivier Tournilhac

Open source

DOI: 10.1097/hs9.0000000000000675
Published: 2022-02
Container: HemaSphere
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1097/hs9.0000000000000675,
  title = {Azacytidine and Venetoclax in Relapsed and Refractory Patients With Angioimmunoblastic T-cell Lymphoma},
  author = {Kamel Laribi and Alix Baugier de Materre and Yamina Touileb and Charles Boursot and Jeremy Sandrini and Doriane Cavalieri and Cédric Pastoret and Laurence de Leval and Olivier Tournilhac},
  year = {2022},
  journal = {HemaSphere},
  doi = {10.1097/hs9.0000000000000675},
  url = {https://doi.org/10.1097/hs9.0000000000000675}
}

RIS

TY  - JOUR
TI  - Azacytidine and Venetoclax in Relapsed and Refractory Patients With Angioimmunoblastic T-cell Lymphoma
AU  - Kamel Laribi
AU  - Alix Baugier de Materre
AU  - Yamina Touileb
AU  - Charles Boursot
AU  - Jeremy Sandrini
AU  - Doriane Cavalieri
AU  - Cédric Pastoret
AU  - Laurence de Leval
AU  - Olivier Tournilhac
PY  - 2022
JO  - HemaSphere
DO  - 10.1097/hs9.0000000000000675
UR  - https://doi.org/10.1097/hs9.0000000000000675
ER  -

APA

Laribi, K., Materre, A. B. D., Touileb, Y., Boursot, C., Sandrini, J., Cavalieri, D., Pastoret, C., Leval, L. D., & Tournilhac, O. (2022). Azacytidine and Venetoclax in Relapsed and Refractory Patients With Angioimmunoblastic T-cell Lymphoma. HemaSphere. https://doi.org/10.1097/hs9.0000000000000675

Source records

crossref · retrieved 2026-09-26T19:20:03.268Z